Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016, Article ID 8163456, 5 pages
http://dx.doi.org/10.1155/2016/8163456
Research Article

Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study

1Infectious Diseases Unit, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 90035-903 Porto Alegre, RS, Brazil
2Hospital Infection Control Section, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, 90035-903 Porto Alegre, RS, Brazil

Received 19 March 2015; Accepted 23 September 2015

Copyright © 2016 Angélica Cechinel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Stryjewski and G. R. Corey, “Methicillin-resistant Staphylococcus aureus: an evolving pathogen,” Clinical Infectious Diseases, vol. 58, supplement 1, pp. S10–S19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. I. M. Gould, “MRSA bacteraemia,” International Journal of Antimicrobial Agents, vol. 30, supplement 1, pp. 66–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Ganga, K. Riederer, M. Sharma et al., “Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center,” Journal of Clinical Microbiology, vol. 47, no. 3, pp. 590–595, 2009. View at Publisher · View at Google Scholar
  4. M. E. A. de Kraker, M. Wolkewitz, P. G. Davey, and H. Grundmann, “Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 4, pp. 1598–1605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Gómez, E. García-Vázquez, R. Baños et al., “Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 26, no. 4, pp. 239–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference,” Critical Care Medicine, vol. 31, no. 4, pp. 1250–1256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, CLSI Document M7-A8, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 8th edition, 2008.
  8. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing. 17th Informational Supplement, M100-S22, CLSI, Wayne, Pa, USA, 2012.
  9. K. Boye, M. D. Bartels, I. S. Andersen, J. A. Møller, and H. Westh, “A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V,” Clinical Microbiology and Infection, vol. 13, no. 7, pp. 725–727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Gilot, G. Lina, T. Cochard, and B. Poutrel, “Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis,” Journal of Clinical Microbiology, vol. 40, no. 11, pp. 4060–4067, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. National Nosocomial Infections Surveillance System, “National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004,” American Journal of Infection Control, vol. 32, no. 8, pp. 470–485, 2004. View at Publisher · View at Google Scholar
  12. M. Guzmán-Blanco, C. Mejía, R. Isturiz et al., “Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America,” International Journal of Antimicrobial Agents, vol. 34, no. 4, pp. 304–308, 2009. View at Publisher · View at Google Scholar
  13. H. Sader, R. N. Jones, A. C. Gales, J. B. Silva, A. C. Pignatari, and SENTRY Participants Group, “SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001,” Brazilian Journal of Infectious Diseases, vol. 8, no. 1, pp. 25–79, 2004. View at Publisher · View at Google Scholar
  14. A. C. Gales, H. S. Sader, J. Ribeiro, C. Zoccoli, A. Barth, and A. C. Pignatari, “Antimicrobial susceptibility of Gram-Positive bacteria isolated in Brazilian hospitals participating in the SENTRY program (2005–2008),” The Brazilian Journal of Infectious Diseases, vol. 13, no. 2, pp. 90–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Ribas, C. Freitas, and P. P. Gontijo-Filho, “Nosocomial methicillin-resistant Staphylococcus aureus bacteremia in a tertiary care hospital: risk factors, overall mortality and antimicrobial resistance,” International Journal of Medicine and Medical Sciences, vol. 1, no. 10, pp. 412–417, 2009. View at Google Scholar
  16. A. C. Kalil, T. C. Van Schooneveld, P. D. Fey, and M. E. Rupp, “Association between vancomycin minimum inhibitory concentration and mortality among patients with staphylococcus aureus bloodstream infections: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 312, no. 15, pp. 1552–1564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Gu, T. Kelesidis, S. Tsiodras, J. Hindler, and R. M. Humphries, “The emerging problem of linezolid-resistant Staphylococcus,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 1, pp. 4–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. B. Patel, L. A. Jevitt, J. Hageman, L. C. McDonald, and F. C. Tenover, “An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus,” Clinical Infectious Diseases, vol. 42, no. 11, pp. 1652–1653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. A. Moise-Broder, G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering Jr., “Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy,” Clinical Infectious Diseases, vol. 38, no. 12, pp. 1700–1705, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. T. de Sanctis, A. Swami, K. Sawarynski et al., “Is there a clinical association of vancomycin MIC Creep, agr Group II Locus, and treatment failure in MRSA bacteremia?” Diagnostic Molecular Pathology, vol. 20, no. 3, pp. 184–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Han, P. H. Edelstein, W. B. Bilker, and E. Lautenbach, “The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia,” Journal of Infection, vol. 66, no. 1, pp. 41–47, 2013. View at Publisher · View at Google Scholar · View at Scopus